Symptomatic medication of 97 patients with multiple system atrophy parkinsonian subtype: An observational study

In the study the considerable proportion of MSA-P patients received high levels of dopaminergic medication chronically. Its efficacy on MSA is still uncertain and further studies with standardised clinical efficacy monitoring are highly welcome.